Market News / Story
FluoGuide (FLUO) Begins US Phase II Enrollment for FG001
·
FluoGuide has started enrolment in its US phase II trial of FG001 in high-grade glioma, its first trial under a US IND. The move follows a collaboration agreement with Leica Microsystems focused on the same indication. Material Details #DetailAI Analyst View1US phase II enrolment startedMarks operational progress that can de-risk timelines and support valuation.2First trial under US INDEntry into the US regulatory path can expand future market potential.3Target:…